E2 ModeratePreliminaryPEM requiredMechanisticPeer-reviewedReviewed
A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Rahim Esfandyarpour, Aref Kashi, Maya Nemat-Gorgani et al. · Proceedings of the National Academy of Sciences (PNAS) · 2019 · DOI
Quick Summary
Stanford researchers developed a nanoelectronics device that detects immune cell changes using a tiny electrical sensor. When salt stress was applied to blood samples, ME/CFS patient samples showed a distinctly different electrical response compared to healthy controls. This 'nano-needle' assay could potentially serve as an objective diagnostic test.
Why It Matters
This study represents progress toward an objective biological test for ME/CFS. The dramatic difference in immune cell response to stress challenge distinguishes ME/CFS samples from healthy controls with high accuracy in this initial study.
Observed Findings
- ME/CFS patient blood samples demonstrated distinctly different electrical responses compared to healthy controls when exposed to salt stress
- A nanoelectronics device with tiny electrical sensors successfully detected immune cell changes in blood samples
- The 'nano-needle' assay produced measurable and reproducible electrical signal differences between patient groups
Inferred Conclusions
- Immune cell dysfunction in ME/CFS may be detectable through altered electrical properties under osmotic stress
- This nanoelectronics approach could potentially provide an objective biomarker for ME/CFS diagnosis
Remaining Questions
- Does this electrical signal differentiate ME/CFS from other fatiguing conditions (chronic Lyme disease, myositis, etc.)?
- What is the biological mechanism underlying the altered electrical response in ME/CFS immune cells?
- Will the assay demonstrate consistent sensitivity and specificity across larger and more diverse patient populations?
What This Study Does Not Prove
This is a small proof-of-concept study. The assay needs validation in larger independent cohorts and comparison with other fatiguing conditions before clinical use. The mechanism behind the altered electrical signal is not fully understood.
Tags
Method Flag:PEM_DEFINEDSmall SampleEXPLORATORYBIOLOGICALLY_RELEVANTExploratory Only
Biomarker:Blood Biomarker
Metadata
- DOI
- 10.1073/pnas.1901274116
- Sample size
- 40 patients
- Control group
- Yes
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.